Stay updated on Olaparib Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib Plus Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T00:19:24.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision history now shows Revision: v3.5.0 added and Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-20T03:49:06.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the version history.
    Difference
    0.0%
    Check dated 2026-03-05T19:27:02.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-12T02:11:03.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0, a minor update with no changes to study data or visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:58:21.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option, implemented green/red highlights for additions/deletions, and updated the footer with Revision: v3.4.0; removed the old 'No FEAR Act data' entry and the v3.3.4 label.
    Difference
    0.3%
    Check dated 2026-01-28T20:25:28.000Z thumbnail image

Stay in the know with updates to Olaparib Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.